cover
Contact Name
Sandy Theresia
Contact Email
sandytheresia.md@gmail.com
Phone
+6285350877763
Journal Mail Official
journalmanager@macc.perdatin.org
Editorial Address
Jl. Cempaka Putih Tengah II No. 2A, Cempaka Putih, Central Jakarta City, Jakarta 10510
Location
Kota adm. jakarta pusat,
Dki jakarta
INDONESIA
Majalah Anestesia & Critical Care (MACC)
Published by Perdatin Jaya
ISSN : -     EISSN : 25027999     DOI : https://doi.org/10.55497/majanestcricar.xxxxx.xxx
Core Subject : Health,
We receive clinical research, experimental research, case reports, and reviews in the scope of all anesthesiology sections.
Articles 313 Documents
Anestesi SAYGO untuk Intubasi Sadar Selama Tiroidektomi dan Sternotomi: Laporan Kasus Sidabutar, Beny Pratama; Ra Ratumasa, Marilaeta Cindryani; Tjokorda Gde Agung Senapathi; Labobar, Otniel Adrians
Majalah Anestesia & Critical Care Vol 43 No 3 (2025): Oktober
Publisher : Perhimpunan Dokter Spesialis Anestesiologi dan Terapi Intensif (PERDATIN) / The Indonesian Society of Anesthesiology and Intensive Care (INSAIC)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55497/majanestcricar.v43i3.443

Abstract

Pendahuluan: Teknik anestesi Spray-As-You-Go (SAYGO) merupakan metode terstruktur yang efektif dalam menangani intubasi sadar pada pasien dengan jalan napas sulit. Deskripsi Kasus: Laporan ini menyajikan kasus seorang wanita berusia 59 tahun dengan tiroid multinodular retrosternal (MNT) besar yang menyebabkan kompresi dan deviasi trakea. Dalam kasus ini, dilakukan intubasi fiberoptik terjaga menggunakan teknik SAYGO, dengan pendekatan kombinasi anestesi topikal lidokain, sedasi deksmedetomidin, dan oksigenasi adekuat. Prosedur diawali dengan nebulisasi lidokain, diikuti dengan penyemprotan lidokain intratrakeal 2% selama proses intubasi fiberoptik, kemudian dilanjutkan dengan induksi anestesi umum menggunakan propofol dan atrakurium setelah intubasi berhasil. Simpulan: Teknik SAYGO terbukti mampu menjaga kenyamanan pasien, mempertahankan patensi jalan napas, dan meminimalkan fluktuasi hemodinamik, sehingga meningkatkan tingkat keberhasilan dan keselamatan intubasi. Pendekatan ini sangat bermanfaat terutama pada kasus dengan kompresi trakea akibat massa tiroid atau mediastinum, karena mampu menurunkan risiko komplikasi dan meningkatkan keberhasilan prosedur.
Opioid-Free Anesthesia as a Part of Multimodal Anesthesia Approach in Modified Radical Mastectomy: A Case Report Togi Stanislaus Patrick; Sinardja, Cynthia Dewi; Senapathi, Tjokorda Gde Agung; Ra Ratumasa, Marilaeta Cindryani
Majalah Anestesia & Critical Care Vol 43 No 3 (2025): Oktober
Publisher : Perhimpunan Dokter Spesialis Anestesiologi dan Terapi Intensif (PERDATIN) / The Indonesian Society of Anesthesiology and Intensive Care (INSAIC)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55497/majanestcricar.v43i3.445

Abstract

Introduction: The shift towards opioid-free anesthesia (OFA) reflects a growing effort to enhance patient safety and reduce opioid-related adverse effects, particularly in oncology surgeries such as modified radical mastectomy (MRM). Case Description: We describe the anesthetic management of a 51-year-old female with infiltrating ductal carcinoma of the left breast who underwent MRM under an opioid-free anesthetic protocol. Induction was performed with propofol via target-controlled infusion (TCI), followed by intraoperative dexmedetomidine infusion for sedation and analgesia. An ultrasound-guided erector spinae plane (ESP) block at the T5 level was performed with 0.375% ropivacaine and dexamethasone to provide regional analgesia. Intraoperative hemodynamics remained stable, no rescue opioids were required, and blood loss was minimal. Postoperative pain control was achieved with a low-dose dexmedetomidine infusion, intravenous ketorolac, and oral paracetamol. The patient reported minimal pain (NRS 0–1/10), had no nausea, vomiting, or respiratory depression, and recovered uneventfully. Conclusion: OFA offers oncological advantages by preserving immune function and reducing tumor- promoting factors, making it a promising alternative in cancer surgery. This report supports the feasibility and benefits of OFA in major breast cancer procedures, underscoring its role in enhancing recovery and potentially improving long-term oncologic outcomes.
Dexamethasone as Prophylaxis of Postoperative Nausea and Vomiting in Cardiothoracic Surgery: Systematic Review and Meta-Analysis Wibowo, Marcell Dion; Ratumasa, Marilaeta Cindryani Ra; Ningrat, I Ketut Jaya; Adi, Made Septyana Parama; Krisnayana, Anak Agung Gede
Majalah Anestesia & Critical Care Vol 43 No 3 (2025): Oktober
Publisher : Perhimpunan Dokter Spesialis Anestesiologi dan Terapi Intensif (PERDATIN) / The Indonesian Society of Anesthesiology and Intensive Care (INSAIC)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55497/majanestcricar.v43i3.450

Abstract

Introduction: Postoperative nausea and vomiting (PONV) remain common and distressing complications following surgery, particularly after high-risk procedures such as cardiothoracic surgeries. Dexamethasone, a corticosteroid with anti-inflammatory and antiemetic effects, has been widely investigated for its role in PONV prevention. This study aimed to evaluate the efficacy of dexamethasone in reducing the incidence of PONV among patients undergoing cardiothoracic surgery through a systematic review and meta-analysis. Methods: The systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Randomized Controlled Trials (RCTs) comparing dexamethasone with placebo or no intervention in cardiothoracic surgery were included. The primary outcome was the incidence of PONV within 24 hours postoperatively; secondary outcomes included the need for rescue antiemetics and the occurrence of adverse effects such as hyperglycemia or infection. Statistical analysis was conducted using Review Manager 5.4, with heterogeneity assessed by the I² and Q/df tests. Results: Four RCTs published between 2018 and 2023 were included, showing low risk of bias and symmetrical funnel plots. The pooled analysis demonstrated a statistically significant reduction in PONV with dexamethasone (OR = 0.57, 95% CI = 0.41–0.80, p = 0.001, I² = 9%, Q/df = 0.98). Conclusion: Dexamethasone significantly reduces the incidence of PONV in patients undergoing cardiothoracic surgery with consistent findings across studies. Further large-scale RCTs are needed to confirm long-term safety and optimize clinical protocols.